when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News

Hubs

Topics
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

pharmadog
drugs
SL-901

drug

SL-901

updated 3mo ago

by Stemline Therapeutics Inc

community read0 votes

🐶 often sniffed alongside

top 7

tagOncology6 co-mentions · 2 sources
drugUndisclosed2 co-mentions · 2 sources
drugRare Disease2 co-mentions · 2 sources
tagPulmonology2 co-mentions · 2 sources
tagRare Disease2 co-mentions · 2 sources
tagNSCLC2 co-mentions · 2 sources
companyStemline Therapeutics Inc2 co-mentions · 2 sources

all catalysts(2)

constraining patent expiry europe · 1

constraining patent expiry europe

Stemline Therapeutics Inc — SL-901 (Constraining Patent Expiry (Europe))

patent expiry · 1

Stemline Therapeutics Inc — SL-901 (Constraining Patent Expiry (Japan))

Trials studying SL-901

phase1Study of the PI3K Inhibitor SL-901 in Patients With Advanced Solid Tumorsterminatedn=20

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov

last refreshed 6m ago

Found something off?

🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?